Comparison of immunogen designs that optimize peptide coverage: Reply to Fischer et al. [2]

PLoS Computational Biology

Volumn 4, Issue 1, 2008, Pages 0178-0180

  Nickle, David C ^a   Jojic, Nebojsa ^f   Heckerman, David ^c   Jojic, Vladimir ^d   Kirovski, Darko ^c   Rolland, Morgane ^b   Pond, Sergei Kosakovsky ^e   Mullins, James I ^b  

^a ROSETTA INPHARMATICS   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MICROSOFT RESEARCH   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGENS;

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN;

ALGORITHM; CD8+ T LYMPHOCYTE; CENTER OF TREE SEQUENCE; DRUG DESIGN; GENE SEQUENCE; GENETIC RECOMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; VACCINE PRODUCTION; ANTIGENIC VARIATION; EPITOPE MAPPING; GENETICS; IMMUNOLOGY; METHODOLOGY; NOTE;

AIDS VACCINES; ANTIGENIC VARIATION; EPITOPE MAPPING; HUMANS;

EID: 38949193298     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0040025     Document Type: Letter

References (13)

1. Nickle DC, Rolland M, Jensen MA, Pond SL, Deng W, et al. (2007) Coping with viral diversity in HIV vaccine design. PLoS Comput Biol 3: e75. doi:10.1371/journal.pcbi.0030075
2. th Annual Conference on Neural Information Processing Systems;5-10 December 2005; Whistler, British Columbia, Canada.
3. Fischer W, Perkins S, Theiler J, Bhattacharya T, Yusim K, et al. (2007) Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat Med 13: 100-106.
4. Fischer W, Liao HX, Haynes BF, Letvin NL, Korber B (2007) Coping with viral diversity in HIV vaccine design: A response to Nickle et al. PLoS Comput Biol 4: e15. doi:10.1371/journal.pcbi.0040015
5. Kirovski D, Heckerman D, Jojic N (2007) Combinatorics of the vaccine design problem: Definition and an algorithm. Microsoft Research Technical Report MSR-TR-2007-2148.
6. Dorrell L (2006) Therapeutic immunization for the control of HIV-1: Where are we now? Int J STD AIDS 17: 436-441.
7. Goonetilleke N, Moore S, Dally L, Winstone N, Cebere I, et al. (2006) Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankaradoi: vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J Virol 80: 4717-4728.
8. Subbramanian RA, Kuroda MJ, Charini WA, Barouch DH, Costantino C, et al. (2003) Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys. J Virol 77: 10113-10118.
9. Subbramanian RA, Charini WA, Kuroda MJ, Seaman M, Chhay H, et al. (2006) Expansion after epitope peptide exposure in vitro predicts cytotoxic T lymphocyte epitope dominance hierarchy in lymphocytes of vaccinated mamu-a*01+ rhesus monkeys. AIDS Res Hum Retroviruses 22: 445-452.
10. De Groot AS, Marcon L, Bishop EA, Rivera D, Kutzler M, et al. (2005) HIV vaccine development by computer assisted design: The GAIA vaccine. Vaccine 23: 2136-2148.
11. Thomson SA, Jaramillo AB, Shoobridge M, Dunstan KJ, Everett B, et al. (2005) Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use. Vaccine 23: 4647-4657.
12. Rolland M, Nickle DC, Mullins JI (2007) HIV-1 group M conserved elements vaccine. PLoS Pathogens 3: e157. doi:10.1371/journal.ppat.0030157
13. Jojic N, Frey B, Kannan A (2003) Epitomic analysis of appearance and shape. Washington (D.C.): IEEE Computer Society. pp. 34-43.